Systematic Review
Accepted on 17 Jan 2024
Global trends in research on MOG antibody-associated disease: Bibliometrics and visualization analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1278867
Type at least 3 characters
1,161 articles
Articles
Original Research
Accepted on 17 Jan 2024
CSF levels of Chitinase3like1 correlate with early response to cladribine in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1343892
Original Research
Accepted on 17 Jan 2024
Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1303937
Review
Published on 16 Jan 2024
Harnessing filamentous phages for enhanced stroke recovery
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1343788
- 177 views
Correction
Published on 16 Jan 2024
Corrigendum: Plasma exchange for two patients with autoimmune GFAP astrocytopathy with rapid progression to respiratory failure: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1366725
Original Research
Accepted on 15 Jan 2024
In Patients with Mild Disability NMOSD: Is the Alteration in the Cortical Morphological or Functional Network Topological Properties More Significant
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1345843
Original Research
Published on 15 Jan 2024
Microglia depletion/repopulation does not affect light-induced retinal degeneration in mice
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1345382
- 244 views
Original Research
Accepted on 12 Jan 2024
Risk factors of neuropathic pain in multiple sclerosis: a retrospective case-cohort study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1309583
Editorial
Published on 11 Jan 2024
Editorial: The molecular basis of programmed cell death and neuroinflammation in neurodegenerative diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1359136
Original Research
Published on 11 Jan 2024
Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1336187
- 172 views
Original Research
Accepted on 09 Jan 2024
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1344184
Review
Accepted on 09 Jan 2024
Involvement of Neuronal Factors in Tumor Angiogenesis and the Shaping of the Cancer Microenvironment
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1284629
Original Research
Accepted on 08 Jan 2024
Causal Relationship Study between Immune Cells and Neurodegenerative Diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1339649
Original Research
Published on 08 Jan 2024
Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1293100
Editorial
Published on 05 Jan 2024
Editorial: Epstein-Barr Virus and multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1330181
- 309 views
Review
Accepted on 03 Jan 2024
Impact of Inflammation and Treg Cell Regulation on Neuropathic Pain in Spinal Cord Injury: Mechanisms and Therapeutic Prospects
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1334828